You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 43598-0367


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 43598-0367

Drug Name NDC Price/Unit ($) Unit Date
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.30748 EACH 2024-12-18
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.25418 EACH 2024-11-20
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.39422 EACH 2024-10-23
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.35676 EACH 2024-09-18
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.36251 EACH 2024-08-21
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.29104 EACH 2024-07-17
CINACALCET HCL 30 MG TABLET 43598-0367-30 0.40228 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 43598-0367

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

43598-0367 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 43598-0367: Cinacalcet

Introduction

The pharmaceutical market is a complex and dynamic environment, influenced by various factors such as regulatory changes, patent expirations, and global health trends. This article focuses on the market analysis and price projections for Cinacalcet, a drug identified by the National Drug Code (NDC) 43598-0367, manufactured by Dr. Reddy's Laboratories Inc.

Drug Overview

Cinacalcet is a calcimimetic agent used primarily to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia in patients with parathyroid carcinoma. It works by mimicking calcium on the parathyroid gland, thereby reducing parathyroid hormone secretion[5].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is facing significant challenges and opportunities in 2025. Key trends include:

Pricing and Access

Pricing and access to drugs are major concerns for the life sciences industry. Nearly half of the C-suite executives surveyed expect these issues to significantly impact their strategies in 2025. This is particularly relevant for drugs like Cinacalcet, which may face pricing pressures due to regulatory and market dynamics[3].

Generic and Biosimilar Competition

The rise of generic drugs and biosimilars is a significant trend. With many high-revenue drugs facing patent expirations, generic and biosimilar versions are likely to enter the market, potentially affecting the pricing and market share of branded drugs like Cinacalcet[3].

Global Price Disparities

The average price per unit of prescription drugs in the U.S. is significantly higher than in other parts of the world. For example, in 2022, U.S. prices were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times those in the rest of the world. This disparity can influence pricing strategies and market access for drugs like Cinacalcet[4].

Price Trends for Cinacalcet

To project the prices of Cinacalcet (NDC 43598-0367), we need to consider several factors:

Historical Pricing

While specific historical price data for NDC 43598-0367 is not provided, the general trend in the pharmaceutical industry is towards increasing prices. For instance, the median price increase for brand name drugs was 13.4% in 2022, which could serve as a benchmark for future price adjustments[2].

Competitive Landscape

The presence of generic or biosimilar versions of Cinacalcet can significantly impact its pricing. If generic versions enter the market, they could reduce the price of Cinacalcet by increasing competition.

Regulatory Environment

Regulatory changes and compliance requirements can also affect pricing. For example, the Open Payments system requires accurate reporting of payments and drug information, which can influence how manufacturers price their drugs to maintain compliance and market share[1].

Price Projections

Given the current trends and factors:

Short-Term Projections

In the short term (2025-2026), the price of Cinacalcet (NDC 43598-0367) is likely to follow the general trend of increasing prices in the pharmaceutical industry. A moderate increase of around 10-15% per year could be expected, aligning with the median price increase for brand name drugs.

Long-Term Projections

In the long term, the entry of generic or biosimilar versions could significantly reduce the price of Cinacalcet. If a generic version is approved and enters the market, the price could drop by 50-70% or more, as is typical with the introduction of generic competition.

Market Size and Growth

The overall market size for prescription drugs, including those like Cinacalcet, has been growing. However, the growth in sales revenues in the U.S. has been driven more by price increases than by volume growth. This trend suggests that while the market size may continue to grow, it will be influenced more by pricing strategies than by an increase in the number of prescriptions[4].

Digital Transformation and Innovation

The life sciences industry is undergoing significant digital transformation, which could impact the pricing and market dynamics of drugs like Cinacalcet. Advances in genomics, biomarkers, and personalized medicine are expected to improve treatment efficacy and reduce side effects, potentially leading to higher demand and different pricing models[3].

Key Takeaways

  • Pricing Trends: The price of Cinacalcet is likely to increase in the short term but could drop significantly with the entry of generic or biosimilar versions.
  • Market Dynamics: Global price disparities, regulatory changes, and the rise of generic and biosimilar drugs will influence the market for Cinacalcet.
  • Digital Transformation: Advances in technology and personalized medicine could impact the demand and pricing of Cinacalcet.
  • Regulatory Compliance: Accurate reporting and compliance with systems like the Open Payments system are crucial for maintaining market share.

FAQs

Q: What is Cinacalcet used for? A: Cinacalcet is used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia in patients with parathyroid carcinoma.

Q: How does Cinacalcet work? A: Cinacalcet works by mimicking calcium on the parathyroid gland, thereby reducing parathyroid hormone secretion.

Q: What are the key trends affecting the price of Cinacalcet? A: Key trends include pricing and access issues, competition from generic and biosimilar drugs, and global price disparities.

Q: How might digital transformation impact the market for Cinacalcet? A: Digital transformation, including advances in genomics and biomarkers, could improve treatment efficacy and lead to different pricing models.

Q: What is the expected impact of generic or biosimilar versions on the price of Cinacalcet? A: The entry of generic or biosimilar versions could reduce the price of Cinacalcet by 50-70% or more.

Sources

  1. CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions Calendar Year 2024.
  2. DrugPatentWatch: Latest drug prices and trends for NDC 00378-2245.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. ASPE: International Market Size and Prices.
  5. FindACode: Dr. Reddy's Laboratories Inc. - List of Drugs - NDC Labeler.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.